Y. Kitamura et al., NOVEL GERMLINE RET PROTOONCOGENE MUTATIONS ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA (MTC) - MUTATION ANALYSIS IN JAPANESE PATIENTS WITH MTC, Oncogene, 14(25), 1997, pp. 3103-3106
Germ-like and somatic mutations in the RET protooncogene are associate
d with inherited and sporadic medullary thyroid carcinoma (MTC). The m
ajority of patients with multiple endocrine neoplasia type 2A (MEN2A)
and familial medullary thyroid carcinoma (FMTC) carry germ-line point
mutations that result in the substitution of one of five cysteine resi
dues. We investigated exons 10, 11, 13, 14 and 16 of the RET proto-onc
ogene in 33 unrelated Japanese patients with MTC. Eleven of the 33 cas
es (33%) were found to have germ-line mutations. Three previously unre
ported mutations in exon 10 and 11 were identified: one in codon 620,
(TGC-->GGC), resulting in a cysteine to glycine substitution, and two
in codon 630, (TGC-->TCC) and (TGC-->TAC), resulting in cysteine to se
rine and cysteine to tyrosine changes, respectively. The new mutations
were present in the germ-line DNA of four unrelated patients for whom
a family history of MTC had not been documented. Because the new RET
alleles described here involve cysteine residues in a region of protei
n previously associated with FMTC and MEN2A, it is very likely that th
ey represent mutations that predispose to the development of MTC.